Jiangsu yew Pharmaceutical Co., Ltd. is a biopharmaceutical enterprise belonging to cardboard cosmetic packaging Hongdou Group. The company has built 42000 square meters standard workshop according to GMP standard, with a total investment of 180 million yuan.
The company has formed a series of anti-tumor product lines based on Paclitaxel; it can extract 300 kg paclitaxel products every year; the products include paclitaxel, docetaxel, carbataxel, 10-DAB, oxaliplatin, ramosetron hydrochloride and other anti-tumor raw materials. It has built an industrial chain from cultivation of Taxus resources to processing of branches and leaves of Taxus chinensis, extract of taxol, initial products of paclitaxel, fine products of paclitaxel and its preparations. It has become a high-tech leading enterprise in the purification and processing of taxol in China.
The company has set up a research institute and employed Dr. overseas returnees to lead the research shoe packaging box and development of new products, ensuring the innovation of products; there are 4 doctors and more than 20 middle and senior talents, and different new products are launched every year.
The company's paclitaxel product DMF has obtained the registration number (25759) of the US FDA, and has been registered in South Korea, India, Iran and white